Final, Group 3, Phase II Trials, page-18

I don't think anyone is expecting any trial results before August 2017 at the earliest. However they will announce when group 3 is treated in February which will hopefully mean 18 patients treated without incident. This would not be a bad achievement (even if expected) as it's definitely a step up from the 4 patients treated in the first trial.
Also the closer we get to August you'd expect there to be slightly higher chance of a successful result, assuming no negative news, simply because it means they've gone for 6-9 months without any major problems.

Personally I'd be interested to see a more detailed announcement about their planned commercialisation. E.g what kind of profit are they expecting in 2018 assuming they get consent to treat paying patients. Even something general like what profit per patient treated they can get would be great to know. Also what scale up plans if any to treat more patients with the extra money they got from the private raising.
At least hoping we'll see some interesting news during that waiting period.